Axsome Therapeutics

top of page

2 days ago

With three approved products and filings for more over the near term, Axsome's CEO describes the scale and reach this company is building in the CNS space

Herriot Tabuteau updates us on the commercialization of Auvelity and Sunosi, launch plans for the recently approved Symbravo, as well as...

Axsome's CEO on the launches of Auvelity and Sunosi, and the year ahead

Jan 22, 2024

Company News

Axsome's CEO on the launches of Auvelity and Sunosi, and the year ahead

Herriot Tabuteau on his company's recent launches, submissions migraine and fibromyalgia, key data in narcolepsy and Alzheimer's, and more.

Follow BiotechTV

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

At Savills, the Life Sciences Team specializes in helping biotech companies unlock their full potential by aligning real estate strategies with their scientific and business goals. As a leading global commercial real estate advisory firm, we focus exclusively on occupier services and tenant representation, acting as a trusted partner to some of the most innovative companies in the industry.

Visit Savills' Life Sciences Overview

bottom of page

With three approved products and filings for more over the near term, Axsome's CEO describes the scale and reach this company is building in the CNS space

Axsome's CEO on the launches of Auvelity and Sunosi, and the year ahead

Follow BiotechTV

Sponsors

Sponsor Spotlight